Phase 3 EOS Clinical Trials
17 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–17 of 17 trials
Recruiting
Phase 2Phase 3
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Metastatic OsteosarcomaHigh Grade OsteosarcomaLocalized Osteosarcoma+1 more
National Cancer Institute (NCI)1,122 enrolled194 locationsNCT05691478
Recruiting
Phase 3
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
OsteosarcomaMetastatic Malignant Neoplasm in the LungMetastatic Osteosarcoma
Children's Oncology Group62 enrolled232 locationsNCT05235165
Recruiting
Phase 3
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
eosinophilic esophagitis
Dr. Falk Pharma GmbH308 enrolled26 locationsNCT06596252
Recruiting
Phase 3
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)
AstraZeneca14 enrolled15 locationsNCT06512883
Recruiting
Phase 3
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE)
Regeneron Pharmaceuticals20 enrolled8 locationsNCT07112378
Recruiting
Phase 3
SIM0718 Treatment of Asthma Clinical Study
Asthma; Eosinophilic
Simcere Pharmaceutical Co., Ltd418 enrolled1 locationNCT06488755
Recruiting
Phase 3
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
AstraZeneca400 enrolled157 locationsNCT06750289
Recruiting
Phase 3
A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
Asthma With Eosinophilic Phenotype
Guangdong Hengrui Pharmaceutical Co., Ltd400 enrolled1 locationNCT06653322
Recruiting
Phase 2Phase 3
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
Eosinophilic Granulomatosis With Polyangiitis
Guangdong Hengrui Pharmaceutical Co., Ltd166 enrolled2 locationsNCT05979051
Recruiting
Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
Hypereosinophilic Syndrome
GlaxoSmithKline123 enrolled91 locationsNCT05334368
Recruiting
Phase 2Phase 3
Prevention of Hernia After Loop Ileostomy Reversal
Loop Ileostomy
Karolinska Institutet208 enrolled4 locationsNCT03720262
Recruiting
Phase 2Phase 3
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
SarcomaOsteosarcomaSarcoma of Bone+2 more
Blokhin's Russian Cancer Research Center50 enrolled1 locationNCT05057130
Recruiting
Phase 3
Use of GnRHa During Chemotherapy for Fertility Protection
Breast Cancer FemaleSoft Tissue SarcomaAcute Leukemia+3 more
Kenny Rodriguez-Wallberg500 enrolled17 locationsNCT05328258
Recruiting
Phase 2Phase 3
Effect of HMB and vitamin D supplementation on osteosarcopenia in older persons
Osteosarcopenia
Western Health88 enrolled1 locationACTRN12619000636156
Not Yet Recruiting
Phase 3
Two food group elimination diet versus swallowed fluticasone for the management of adult eosinophilic esophagitis, a single- centred randomised prospective study
eosinophilic esophagitis
Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital194 enrolled1 locationACTRN12619000141145
Terminated
Phase 3
A Study to Compare Loperimide to Placebo for the Prevention of Excess Fluid Losses From the Stoma in Patients with New Loop Ileostomy.
High output ileostomyDehydration
Hunter New England Local Health District86 enrolled2 locationsACTRN12614000180617
Recruiting
Phase 3Phase 4
Exogenous Melatonin to Improve Sleep in Critically Ill Patients
Poor sleep in tracheostomised ICU patients.
The Alfred60 enrolled1 locationACTRN12610000008022